Cystoid macular edema, often caused by proinflammatory cytokines altering retinal capillary endothelium or the retinal pigment epithelium, leads to permanent vision loss if untreated. Detection and treatment options, including steroids, systemic steroid-sparing agents, and anti-VEGF agents, play crucial roles in managing macular edema and preserving vision. Various treatments like periocular and intravitreal steroids, intravitreal corticosteroid implants, and systemic therapies, such as antimetabolites or TNF inhibitors, show promise in treating uveitic macular edema.
1. Uveitis is a common cause of vision loss due to cystoid macular edema. 2. Treatment options includefluorescein angiography, steroids, systemic steroid-sparing agents, and anti-VEGF agents. 3. Various steroid-based therapies show promise in managing macular edema. 4. Systemic therapies, including antimetabolites and TNF inhibitors, are effective for chronic uveitis. 5. Targeted delivery methods, such as intravitreal corticosteroid implants and suprachoroidal triamcinolone, offer innovative treatment options.
Listen Tab content
